TYKERB for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 282 adverse event reports in the FDA FAERS database where TYKERB was used for Breast cancer.
Most Reported Side Effects for TYKERB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 173 | 32.5% | 3 | 12 |
| Nausea | 63 | 11.8% | 7 | 10 |
| Death | 47 | 8.8% | 47 | 1 |
| Fatigue | 44 | 8.3% | 3 | 5 |
| Drug ineffective | 42 | 7.9% | 1 | 4 |
| Rash | 37 | 6.9% | 0 | 2 |
| Disease progression | 29 | 5.4% | 10 | 3 |
| Vomiting | 29 | 5.4% | 2 | 7 |
| Decreased appetite | 28 | 5.3% | 3 | 2 |
| Palmar-plantar erythrodysaesthesia syndrome | 23 | 4.3% | 0 | 3 |
| Weight decreased | 23 | 4.3% | 2 | 4 |
| Dizziness | 22 | 4.1% | 4 | 8 |
| Dry skin | 22 | 4.1% | 0 | 1 |
| Stomatitis | 19 | 3.6% | 1 | 2 |
| Malaise | 18 | 3.4% | 0 | 0 |
Other Indications for TYKERB
Product used for unknown indication (133)
Breast cancer metastatic (54)
Breast cancer female (12)
Neoplasm malignant (10)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
PALBOCICLIB (13,075)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)